TipRanks

Notifications

Analysts Offer Insights on Healthcare Companies: Bristol Myers (BMY) and Capital Senior Living (CSU)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol Myers (BMYResearch Report) and Capital Senior Living (CSUResearch Report).

Bristol Myers (BMY)

Barclays analyst Carter Gould maintained a Hold rating on Bristol Myers on July 28 and set a price target of $71.00. The company’s shares closed last Thursday at $68.15, close to its 52-week high of $68.99.

According to TipRanks.com, Gould is a 3-star analyst with an average return of 5.2% and a 44.9% success rate. Gould covers the Healthcare sector, focusing on stocks such as Reata Pharmaceuticals, Travere Therapeutics, and Eli Lilly & Co.

Bristol Myers has an analyst consensus of Moderate Buy, with a price target consensus of $73.50, representing a 6.5% upside. In a report released yesterday, Morgan Stanley also maintained a Hold rating on the stock with a $71.00 price target.

See today’s analyst top recommended stocks >>

Capital Senior Living (CSU)

In a report issued on July 28, Steven Valiquette from Barclays maintained a Sell rating on Capital Senior Living, with a price target of $23.00. The company’s shares closed last Thursday at $30.75.

According to TipRanks.com, Valiquette is a 3-star analyst with an average return of 2.3% and a 56.1% success rate. Valiquette covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Bright Health Group, and AmerisourceBergen.

Currently, the analyst consensus on Capital Senior Living is a Moderate Sell with an average price target of $23.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BMY:

Tags: